Citations 1
Infigratinib (BGJ398): an investigational agent for the treatment of FGFR-altered intrahepatic cholangiocarcinoma
Botrus, Gehan , Raman, Puneet , Oliver, Thomas , Bekaii‐Saab, Tanios , Bekaii-Saab, Tanios S , Oliver, Thomas
Expert Opinion on Investigational Drugs | December 12, 2020 | Volume: 30 | Issue: 4 | Pages: 309-316
